Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor (OMI) delivers critical healthcare logistics solutions across 90+ countries, connecting medical manufacturers with care providers. This dedicated news hub provides verified updates on OMI's operational milestones, financial performance, and industry leadership in medical supply chain management.
Investors and healthcare professionals will find timely reports on earnings announcements, strategic partnerships, and innovations in patient direct services. Our curated collection includes press releases detailing supply chain advancements, product distribution expansions, and operational efficiency initiatives.
The page features essential updates across three key areas: quarterly financial results, major contract awards, and technological improvements in medical logistics. Users can track OMI's role in enhancing healthcare infrastructure through its dual focus on bulk institutional supply and direct-to-patient delivery networks.
Bookmark this resource for streamlined access to Owens & Minor's official communications. Regularly updated content ensures stakeholders maintain current awareness of developments impacting medical supply chain dynamics and healthcare delivery ecosystems.
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2023 on
Owens & Minor, Inc. (NYSE: OMI) announced its executive leadership will participate in a fireside chat at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference. The event is scheduled for Thursday, March 2, at 8:45 a.m. Eastern Time. Interested parties can access the live webcast via the company's investor relations page, with a replay available after the presentation. Owens & Minor, a Fortune 500 healthcare solutions provider, specializes in product manufacturing, delivery, and services for patients both in hospitals and at home. The company has been operating for over 140 years and employs more than 20,000 individuals globally.
Owens & Minor, Inc. (NYSE-OMI) reported impressive Q4 results with a 135% revenue increase in its Patient Direct segment, totaling $2.6 billion consolidated revenue. The operating cash flow stood at $325 million for 2022, up 162% year-over-year. However, challenges persist in the global products division, prompting an Operating Model Realignment Program expected to generate $30 million in adjusted operating income in 2023 and $200 million by 2025. The company anticipates 2023 revenue between $10.1 billion and $10.5 billion, with adjusted EBITDA projected at $490-$550 million.
Owens & Minor, Inc. (NYSE: OMI) is set to announce its financial results for the fourth quarter and full year of 2022 on February 28, 2023, before market opening. A conference call for investors and analysts will follow at 8:00 a.m. ET. Participants can join via a toll-free phone line or through a live webcast on the company’s investor relations page. Owens & Minor is a leading healthcare solutions provider with a focus on supply chain management, PPE manufacturing, and home health services. The company has been operational since 1882 and employs over 20,000 people globally.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
